omeprazole has been researched along with Chlamydia Infections in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrinogen changes were also significantly and negatively correlated with age." | 2.69 | Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. ( Arosio, C; Bertinieri, G; Blasi, F; Ceriani, G; Cosentini, R; Mandelli, C; Perondi, R; Ranzi, ML; Tarsia, P; Tien, TV; Torgano, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takata, K | 1 |
| Fukuda, H | 1 |
| Umeda, K | 1 |
| Yamauchi, R | 1 |
| Fukuda, S | 1 |
| Kunimoto, H | 1 |
| Tanaka, T | 1 |
| Yokoyama, K | 1 |
| Morihara, D | 1 |
| Takeyama, Y | 1 |
| Irie, M | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Torgano, G | 1 |
| Cosentini, R | 1 |
| Mandelli, C | 1 |
| Perondi, R | 1 |
| Blasi, F | 1 |
| Bertinieri, G | 1 |
| Tien, TV | 1 |
| Ceriani, G | 1 |
| Tarsia, P | 1 |
| Arosio, C | 1 |
| Ranzi, ML | 1 |
1 review available for omeprazole and Chlamydia Infections
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomati | 2018 |
1 trial available for omeprazole and Chlamydia Infections
| Article | Year |
|---|---|
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Di | 1999 |